Sudden infant death syndrome laboratory findings

Jump to: navigation, search

Sudden infant death syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sudden infant death syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sudden infant death syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sudden infant death syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sudden infant death syndrome laboratory findings

CDC on Sudden infant death syndrome laboratory findings

Sudden infant death syndrome laboratory findings in the news

Blogs on Sudden infant death syndrome laboratory findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sudden infant death syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S[2]

Overview

There are no diagnostic laboratory findings associated with sudden infant death syndrome (SIDS). Some patients with sudden infant death syndrome (SIDS) may have anemia and infection.

Laboratory Findings

There are no diagnostic laboratory findings associated with sudden infant death syndrome (SIDS).

References

  1. Choi HJ, Kim YH (2016). "Apparent life-threatening event in infancy". Korean J Pediatr. 59 (9): 347–354. doi:10.3345/kjp.2016.59.9.347. PMC 5052132. PMID 27721838.
  2. Chang JY, Schindler P, Ramseier U, Lai PH (1995). "The disulfide folding pathway of human epidermal growth factor". J Biol Chem. 270 (16): 9207–16. doi:10.1074/jbc.270.16.9207. PMID 7721838.
  3. Wijers MM, Semmekrot BA, de Beer HJ, Engelberts AC, Dutch Paediatric Association. Dutch Institute for Healthcare Improvement (CBO) (2009). "[Multidisciplinary guidelines for 'Apparent life threatening event' (ALTE)]". Ned Tijdschr Geneeskd. 153: A590. PMID 20051156.
  4. Kahn, Andr� (2004). "Recommended clinical evaluation of infants with an apparent life-threatening event. Consensus document of the European Society for the Study and Prevention of Infant Death, 2003". European Journal of Pediatrics. 163 (2): 108–115. doi:10.1007/s00431-003-1365-x. ISSN 0340-6199. replacement character in |first1= at position 5 (help)
  5. Kadivar M, Yaghmaie B, Allahverdi B, Shahbaznejad L, Razi N, Mosayebi Z (2013). "Apparent life-threatening events in neonatal period: clinical manifestations and diagnostic challenges in a pediatric referral center". Iran J Pediatr. 23 (4): 458–66. PMC 3883377. PMID 24427501.

Linked-in.jpg